Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Baughman, Andrew L.
Bisgard, Kristine M.
Edwards, Kathryn M.
Guris, Dalya
Decker, Michael D.
Holland, Kathy
Meade, Bruce D.
and
Lynn, Freyja
2004.
Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States.
Clinical and Vaccine Immunology,
Vol. 11,
Issue. 6,
p.
1045.
Nardone, A
Pebody, R.G
Maple, P.A.C
Andrews, N
Gay, N.J
and
Miller, E
2004.
Sero-epidemiology of Bordetella pertussis in England and Wales.
Vaccine,
Vol. 22,
Issue. 9-10,
p.
1314.
Wendelboe, Aaron M.
Van Rie, Annelies
Salmaso, Stefania
and
Englund, Janet A.
2005.
Duration of Immunity Against Pertussis After Natural Infection or Vaccination.
Pediatric Infectious Disease Journal,
Vol. 24,
Issue. 5,
p.
S58.
Versteegh, Florens GA
Schellekens, Joop FP
Fleer, André
and
Roord, John J
2005.
Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management.
Reviews in Medical Microbiology,
Vol. 16,
Issue. 3,
p.
79.
van Boven, Michiel
Mooi, Frits R
Schellekens, Joop F.P
de Melker, Hester E
and
Kretzschmar, Mirjam
2005.
Pathogen adaptation under imperfect vaccination: implications for pertussis.
Proceedings of the Royal Society B: Biological Sciences,
Vol. 272,
Issue. 1572,
p.
1617.
Viet, A.-F.
and
Medley, G.F.
2006.
Stochastic dynamics of immunity in small populations: A general framework.
Mathematical Biosciences,
Vol. 200,
Issue. 1,
p.
28.
Baughman, Andrew L.
Bisgard, Kristine M.
Lynn, Freyja
and
Meade, Bruce D.
2006.
Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels.
Statistics in Medicine,
Vol. 25,
Issue. 17,
p.
2994.
Fraser, Christophe
Tomassini, Joanne E.
Xi, Liwen
Golm, Greg
Watson, Michael
Giuliano, Anna R.
Barr, Eliav
and
Ault, Kevin A.
2007.
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine.
Vaccine,
Vol. 25,
Issue. 21,
p.
4324.
Bailleux, F.
Coudeville, L.
Kolenc-Saban, A.
Bevilacqua, J.
Barreto, L.
and
André, P.
2008.
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data.
Vaccine,
Vol. 26,
Issue. 31,
p.
3903.
Giammanco, Anna
Nardone, Antony
Pebody, Richard
Kafatos, George
Andrews, Nick
Chiarini, Alfredo
Taormina, Susanna
de Ory, Fernando
Prosenc, Katarina
Krize, Bohumir
Hallander, Hans
Ljungman, Margaretha
Marva, Esther
Tsakris, Athanassios
O’Flanagan, Darina
Schneider, François
Griskevicius, Algirdas
Vranckx, Robert
and
Karacs, Ildiko
2008.
European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
Vaccine,
Vol. 26,
Issue. 35,
p.
4486.
SIMONSEN, J.
STRID, M. A.
MØLBAK, K.
KROGFELT, K. A.
LINNEBERG, A.
and
TEUNIS, P.
2008.
Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans.
Epidemiology and Infection,
Vol. 136,
Issue. 7,
p.
895.
Dalby, Tine
Petersen, Jesper Westphal
Harboe, Zitta B.
and
Krogfelt, Karen Angeliki
2010.
Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Journal of Medical Microbiology
,
Vol. 59,
Issue. 9,
p.
1029.
de Greeff, Sabine C.
de Melker, Hester E.
van Gageldonk, Pieter G. M.
Schellekens, Joop F. P.
van der Klis, Fiona R. M.
Mollema, Liesbeth
Mooi, Frits R.
Berbers, Guy A. M.
and
Ratner, Adam J.
2010.
Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis.
PLoS ONE,
Vol. 5,
Issue. 12,
p.
e14183.
Kretzschmar, Mirjam
Teunis, Peter F. M.
Pebody, Richard G.
and
Murray, Megan
2010.
Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries.
PLoS Medicine,
Vol. 7,
Issue. 6,
p.
e1000291.
Rendi-Wagner, Pamela
Tobias, Joshua
Moerman, Larisa
Goren, Sophy
Bassal, Ravit
Green, Manfred
and
Cohen, Dani
2010.
The seroepidemiology of Bordetella pertussis in Israel—Estimate of incidence of infection.
Vaccine,
Vol. 28,
Issue. 19,
p.
3285.
Lavine, Jennie S.
King, Aaron A.
and
Bjørnstad, Ottar N.
2011.
Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.
Proceedings of the National Academy of Sciences,
Vol. 108,
Issue. 17,
p.
7259.
Wang, Chuan-Qing
and
Zhu, Qi-Rong
2011.
Seroprevalence of Bordetella pertussis Antibody in Children and Adolescents in China.
Pediatric Infectious Disease Journal,
Vol. 30,
Issue. 7,
p.
593.
Warfel, Jason M.
Beren, Joel
Kelly, Vanessa K.
Lee, Gloria
Merkel, Tod J.
and
Bliska, J. B.
2012.
Nonhuman Primate Model of Pertussis.
Infection and Immunity,
Vol. 80,
Issue. 4,
p.
1530.
de Greeff, Sabine C.
Teunis, Peter
de Melker, Hester E.
Mooi, Frits R.
Notermans, Daan W.
Elvers, Bert
and
Schellekens, Joop F. P.
2012.
Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples.
Clinical and Vaccine Immunology,
Vol. 19,
Issue. 9,
p.
1452.
Teunis, PFM
van Eijkeren, JCH
Ang, CW
van Duynhoven, YTHP
Simonsen, JB
Strid, MA
and
van Pelt, W
2012.
Biomarker dynamics: estimating infection rates from serological data.
Statistics in Medicine,
Vol. 31,
Issue. 20,
p.
2240.